Exten Industries (fka BB: EXTI)

[Patricia_1]

Notes: Wallstreet Reporter Interview 12/16/03

By: alandail
26 Dec 2003, 12:48 PM EST
Msg. 19486 of 19486
Jump to msg. #
from the wallstreet reporter interview

focus in 2004:

- will introduce additional products that the pharmaceutical industry will use
- know we're producing therapeutic proteins, focus is to demonstrate commercial viability
- adult human stem cells - greater than $30 billion market in 2010. Sounded like he was talking about more than liver stem cells.

potential partnerships - high hopes that some of the pharmaceutical companies that are already familiar with them will become partners on what they are developing (theapeutic proteins, stem cells).

"We are an extremely unusual biotech company in that we have a product on the market today."

"of course, we hope that it'll be a much larger number than that." referring to the $18 million guaranteed minimum revenues.

Talked about the difficulty in testing with any other existing approach and how much better things are with their cells.


http://ragingbull.lycos.com/mboard/boards.cgi?board=EXTI&read=19486